Comment
A strategy to halt leprosy transmission

https://doi.org/10.1016/S1473-3099(13)70365-7Get rights and content

References (11)

  • Scientific working group on leprosy, Geneva, Switzerland

  • Global leprosy situation, 2012

    Wkly Epidemiol Rec

    (2012)
  • WHO Expert Committee on Leprosy: eighth report. Geneva, Switzerland

  • FJ Moet et al.

    Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions

    Lepr Rev

    (2004)
  • FJ Moet et al.

    Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial

    BMJ

    (2008)
There are more references available in the full text version of this article.

Cited by (62)

  • Molecular epidemiology of leprosy: An update

    2020, Infection, Genetics and Evolution
    Citation Excerpt :

    Untreated, leprosy symptoms progress to irreversible physical disabilities such as blindness and limb deformities. Current leprosy control strategies rely on early diagnosis and prompt treatment to minimize the progressive morbidity of leprosy and hopefully interrupt transmission from clinically active cases (Smith et al., 2014). However, this strategy is still not optimally implemented and 5.4% of the new cases were diagnosed with advanced leprosy disabilities in 2018 for which 90% were found in the global priority countries (WHO, 2019).

View all citing articles on Scopus
View full text